InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 04/02/2019 8:40:36 AM

Tuesday, April 02, 2019 8:40:36 AM

Post# of 1738
News: $EVOK Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti(TM) NDA

SOLANA BEACH, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administ...

Read the whole news https://marketwirenews.com/news-releases/evoke-pharma-receives-complete-response-letter-and-recommendations-to-address-deficiencies-from-fda-for-gimoti-tm-nda-7929076.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News